Barclays’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $682K | Buy |
25,758
+5,155
| +25% | +$134K | ﹤0.01% | 3286 |
|
|
2026
Q2 | $539K | Buy |
20,603
+2,229
| +12% | +$56.6K | ﹤0.01% | 3174 |
|
|
2026
Q1 | $460K | Sell |
18,374
-61,592
| -77% | -$1.46M | ﹤0.01% | 3235 |
|
|
2025
Q4 | $2.11M | Sell |
79,966
-119,057
| -60% | -$2.6M | ﹤0.01% | 2896 |
|
|
2025
Q3 | $3.4M | Buy |
199,023
+76,203
| +62% | +$1.09M | ﹤0.01% | 2482 |
|
|
2025
Q2 | $1.54M | Buy |
122,820
+47,390
| +63% | +$565K | ﹤0.01% | 3047 |
|
|
2025
Q1 | $898K | Sell |
75,430
-145,460
| -66% | -$1.98M | ﹤0.01% | 3172 |
|
|
2024
Q4 | $3.23M | Buy |
220,890
+66,506
| +43% | +$930K | ﹤0.01% | 2523 |
|
|
2024
Q3 | $1.94M | Buy |
154,384
+127,595
| +476% | +$1.39M | ﹤0.01% | 2872 |
|
|
2024
Q2 | $228K | Sell |
26,789
-21,515
| -45% | -$192K | ﹤0.01% | 3509 |
|
|
2024
Q1 | $508K | Sell |
48,304
-45,025
| -48% | -$500K | ﹤0.01% | 3581 |
|
|
2023
Q4 | $970K | Buy |
+93,329
| New | +$744K | ﹤0.01% | 3454 |
|
|
2023
Q2 | – | Sell |
-10,900
| Closed | -$98.5K | – | 5156 |
|
|
2023
Q1 | $98.5K | Buy |
+10,900
| New | +$95.1K | ﹤0.01% | 4191 |
|
|
2022
Q4 | – | Sell |
-1,117
| Closed | -$7K | – | 5400 |
|
|
2022
Q3 | $7K | Hold |
1,117
| – | – | ﹤0.01% | 4433 |
|
|
2022
Q2 | $6K | Sell |
1,117
-641
| -36% | -$3.88K | ﹤0.01% | 4760 |
|
|
2022
Q1 | $12K | Buy |
1,758
+641
| +57% | +$5.71K | ﹤0.01% | 4572 |
|
|
2021
Q4 | $18K | Sell |
1,117
-4,769
| -81% | -$99.4K | ﹤0.01% | 3957 |
|
|
2021
Q3 | $170K | Sell |
5,886
-3,672
| -38% | -$122K | ﹤0.01% | 3701 |
|
|
2021
Q2 | $332K | Sell |
9,558
-7,467
| -44% | -$237K | ﹤0.01% | 3302 |
|
|
2021
Q1 | $537K | Buy |
17,025
+15,508
| +1,022% | +$630K | ﹤0.01% | 3135 |
|
|
2020
Q4 | $72K | Hold |
1,517
| – | – | ﹤0.01% | 4265 |
|
|
2020
Q3 | $71K | Sell |
1,517
-82,500
| -98% | -$2.83M | ﹤0.01% | 4426 |
|
|
2020
Q2 | $3.03M | Buy |
+84,017
| New | +$3.09M | ﹤0.01% | 1758 |
|
|
2020
Q1 | – | Sell |
-3,900
| Closed | -$177K | – | 6515 |
|
|
2019
Q4 | $177K | Hold |
3,900
| – | – | ﹤0.01% | 5126 |
|
|
2019
Q3 | $97K | Hold |
3,900
| – | – | ﹤0.01% | 5501 |
|
|
2019
Q2 | $86K | Buy |
+3,900
| New | +$71.6K | ﹤0.01% | 5803 |
|
|
2018
Q3 | – | Sell |
-1,248
| Closed | -$18K | – | 7442 |
|
|
2018
Q2 | $18K | Buy |
+1,248
| New | +$19.3K | ﹤0.01% | 6247 |
|
Other funds holding ZYME
Barclays's ZYME Position: Q3 2026 in Review
Barclays increased its Zymeworks (ZYME) stake by 25% in Q3 2026, buying an estimated $134K and bringing the position to 25,758 shares worth $682K. The position accounts for ﹤0.01% of the portfolio, ranked #3286.
Barclays first reported a position in ZYME in Q2 2018 and has held it in 27 quarters since. The position peaked at $3.4M in Q3 2025. 136 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.
- Barclays held 25,758 shares of Zymeworks worth $682K as of Q3 2026.
- Barclays bought 5,155 Zymeworks shares in Q3 2026, an estimated $134K.
- Zymeworks made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3286 holding.
- Barclays first reported a position in Zymeworks in Q2 2018 and has held it in 27 quarters since.
- Barclays's Zymeworks position peaked at $3.4M in Q3 2025.
- 136 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.